Zhimin Shi

Long Noncoding RNA X-Inactive Specific Transcript Facilitates Cellular Functions in Melanoma via miR-139-5p/ROCK1 Pathway

Yifei Yang, F. Wang, Dongxia Sun, 2020, OncoTargets and therapy.

Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.

Ying Su, Liwei Zhao, Xueling Wang, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy

W-J Ma, Yanni Luo, Jiayang Yin, 2022, Gene therapy.

Regulatory mechanism of miR-146a on MPTP-induced neuroinflammation in mice with Parkinson's disease

Peilan Zhang, H. Mochizuki, Tao Zhang, 2022, Tropical Journal of Pharmaceutical Research.

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.

B. Shi, Zonghai Li, Honghong Zhang, 2018, Journal of the National Cancer Institute.

MicroRNA‐373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/β‐Catenin pathway

Dongxia Sun, Zhimin Shi, Yuanyuan Meng, 2018, Journal of cellular biochemistry.

A Fusion Receptor as a Safety Switch, Detection, and Purification Biomarker for Adoptive Transferred T Cells.

B. Shi, J. Gu, Zonghai Li, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Hua Jiang, Min Zhou, Hong Luo, 2018, Front. Pharmacol..

Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein

Y. Liu, B. Shi, Zonghai Li, 2018, Cancer Immunology, Immunotherapy.